GlassScriptPhysician profile
Agha Khan
NPI 1649336546
$722.67
in general payments reported to CMS, 2019-2025
17 companies · $2.82 in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $75.42 · 2021: $158 · 2022: $107 · 2023: $258 · 2025: $2.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182 · Gift: $59.40 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.72 |
| Gift | $59.40 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $204.08 | 2019-2022 | |
| Mannkind Corporation | $106.50 | 2023 | Afrezza |
| Medtronic, INC. | $75.36 | 2022-2023 | Inpen Smart Insulin Delivery System, Minimed 770g |
| Novo Nordisk INC | $51.90 | 2019-2022 | |
| Dexcom, INC. | $41.51 | 2021-2023 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $36.76 | 2019-2021 | |
| Amgen INC. | $36.01 | 2020-2023 | Repatha |
| Xeris Pharmaceuticals, INC. | $29.68 | 2023 | Gvoke Hypopen |
| Ascendis Pharma Endocrinology INC | $19.71 | 2023 | |
| Radius Health, INC. | $18.56 | 2023 | Tymlos |
| Senseonics, Incorporated | $17.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.17 | 2021 | |
| Lilly USA, LLC | $14.93 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $14.78 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $13.51 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $13.34 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Amarin Pharma, INC. | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Agha Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.